Stay updated on CSL311 Safety and Exposure Study in Asthma Clinical Trial
Sign up to get notified when there's something new on the CSL311 Safety and Exposure Study in Asthma Clinical Trial page.

Latest updates to the CSL311 Safety and Exposure Study in Asthma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe CSL311 asthma study record is available again, with details on its completed Phase 1 trial, eligibility, locations, interventions, and outcome measures.SummaryDifference69%

- Check15 days agoChange DetectedThe site revision identifier changed from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedAn NIH announcement banner was added, stating that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.” The study record itself continues to show a 403 error.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, effectively blocking access to the ClinicalTrials.gov record for NCT04082754; the header shows a 403 message and navigation elements typical of an error page.SummaryDifference21%

Stay in the know with updates to CSL311 Safety and Exposure Study in Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CSL311 Safety and Exposure Study in Asthma Clinical Trial page.